The global pediatric neuroblastoma treatment market stands at a valuation of US$ 2.1 billion in 2023 and is predicted to exhibit expansion at a stellar 9.7% CAGR over the next ten years. As such, worldwide demand for pediatric neuroblastoma treatment is forecasted to rake in a revenue of US$ 5.3 billion by 2033-end.
Neuroblastoma is a common cancer that is often found in the adrenal...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek